Cambridge-grade science
Developed in the University of Cambridge genomics laboratory, refined with practising fertility consultants.
Genomic science, built for reproductive care
A spin-out building the diagnostic infrastructure for reproductive genomics.
Founded 2023 · UK & EU
Our mission
Every reproductive decision deserves science clinicians and patients can act on
The BioBloom Life team
Three principles behind everything we process
Methodology transparency
We publish the technique behind every test and link the evidence — never a black box.
Patient-aware reporting
Written so a clinician can act on them and a patient can understand them.
Our story
A Cambridge spin-out built around clinical reality
BioBloom Life began as a research programme into the endometrial microbiome and its role in implantation, recurrent loss and unexplained infertility. We founded the company to turn that work into a test specialists can order.
Consultants, embryologists and gynaecologists across Europe shape every methodology decision.
2023
Founded out of the University of Cambridge, focused on the endometrial microbiome.
2024
Sequencing methodology refined and clinically validated.
2025
Validated with UK fertility consultants and embryologists.
2026
Clinical pilot with NHS-affiliated and private UK fertility clinics.
Contact us
Let’s talk.
Clinician, prospective clinic partner or journalist — drop us a line and we’ll route it to the right person.
Office
BioBloom Life Ltd
Silverstream House, 45 Fitzroy Street
London, England, W1T 6EB
